The Palomar Lux1440 Handpiece is intended for skin resurfacing procedures in addition to dermatological procedures requiring the coagulation of soft tissue.

Dermatological procedures requiring the coagulation of soft tissue;
Skin resurfacing procedures.

Device Description

The Palomar Lux1440 Handpiece attaches to the StarLux Pulsed Light and Laser System. The complete system consists of a cart, base unit, chiller, a footswitch, and a handpiece.

AI/ML Overview

The provided 510(k) summary for the Palomar Lux1440 Handpiece (K073583) does not contain any information about acceptance criteria or a study proving the device meets said criteria.

Instead, the submission focuses on demonstrating substantial equivalence to predicate devices (K071768 and K061652) based on:

Intended Use: Similar applications (skin resurfacing and dermatological procedures requiring soft tissue coagulation).
Device Description: The Lux1440 Handpiece attaches to the existing StarLux Pulsed Light and Laser System, implying similar underlying technology and components.
Performance Data (as stated by the submitter): A claim that "The review of the technical characteristics, indications for use, mechanism of action, and verification and validation information provided demonstrate that the modified Palomar Lux1440 Handpiece is substantially equivalent to its predicate device."

Therefore, I cannot provide the requested information in the table or the subsequent points because it is not present in the provided text.

The document's purpose is to establish substantial equivalence for regulatory clearance, not to detail specific performance metrics against pre-defined acceptance criteria through a clinical study. The FDA's letter confirms this, stating, "We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent...".

Summary of missing information:

Table of Acceptance Criteria and Reported Device Performance: Not present.
Sample size used for the test set and data provenance: No test set or clinical study is described.
Number of experts used to establish the ground truth and their qualifications: Not applicable as no ground truth establishment is described.
Adjudication method: Not applicable.
Multi reader multi case (MRMC) comparative effectiveness study: Not mentioned.
Standalone (algorithm only without human-in-the-loop performance): Not applicable, as this is a laser handpiece, not an AI algorithm.
Type of ground truth used: Not applicable.
Sample size for the training set: Not applicable, as this is not a machine learning device.
How the ground truth for the training set was established: Not applicable.

Summary

{0}------------------------------------------------

Ko 7 35 83

510(k) Summary Palomar Lux1440 Handpiece

MAR 2 6 2008

This 510(k) summary is being submitted in accordance with 21 CFR 807.92

SUBMITTER'S INFORMATION 1.

NAME:	Palomar Medical Technologies, Inc.
ADDRESS:	82 Cambridge StreetBurlington, MA 01803Phone: (781) 993-2300Fax: (781) 993-2330
CONTACT:	Sharon Timberlake, RAC, CCRADirector of Regulatory Affairs

DATE PREPARED: March 19, 2008

2. DEVICE INFORMATION

	TRADE/PROPRIETARY NAME:	Palomar Lux1440 Handpiece
COMMON NAME:	Lux1440
CLASSIFICATION NAME:	Laser surgical instrument for use in general andplastic surgery and in dermatology(21 CFR §878.4810)
PRODUCT CODE:	GEX

3. PREDICATE DEVICE

Palomar Erbium Fractional Handpiece K071768 Palomar Medical Technologies, Inc.

Palomar Lux1540 Handpiece K061652 Palomar Medical Technologies, Inc.

{1}------------------------------------------------

Ko73583

4. INTENDED USE

The Palomar Lux1440 Handpiece is intended for skin resurfacing procedures in addition to dermatological procedures requiring the coagulation of soft tissue.

DEVICE DESCRIPTION 5.

The Palomar Lux1440 Handpiece attaches to the StarLux Pulsed Light and Laser System. The complete system consists of a cart, base unit, chiller, a footswitch, and a handpiece.

PERFORMANCE DATA 6.

The review of the technical characteristics, indications for use, mechanism of action, and verification and validation information provided demonstrate that the modified Palomar Lux1440 Handpiece is substantially equivalent to its predicate device.

7. SUBSTANTIAL EQUIVALENCE

The Palomar Lux1440 Handpiece was found to be substantially equivalent to its predicate device when used according to its intended use. The information that is provided in this application demonstrates that the Palomar Lux1440 Handpiece also shares similar technological characteristics as its predicate.

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a traditional symbol of medicine, but with a more abstract and modern design.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 2 6 2008

Palomar Medical Technologies, Inc. % Sharon Timberlake, RAC, CCRA Director of Regulatory Affairs 93 Cambridge Street Burlington, Massachusetts 01803

Re: K073583 Trade/Device Name: PalmarLux 1440 Handpiece Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: February 15, 2008 Received: February 19, 2008

Dear Ms. Timberlake:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Sharon Timberlake, RAC, CCRA

forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance. please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Mark N. Wilkinson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): K073583

Device Name: PalomarLux1440 Handpiece

Indications for Use:

Dermatological procedures requiring the coagulation of soft tissue;

Skin resurfacing procedures.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices

510(k) Number K073583

Labels	Values
Prescription Use	X
Over-The-Counter Use

(Per 21 CFR 801.109)

(Optional Format 1-2-96)

Regulation Number and Section

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.